Perioperative clinical outcomes of remimazolam in regional anesthesia: a systematic review of sedation and safety parameters
Remimazolam appears to be an effective and safe sedative option for regional anesthesia, offering a rapid onset and recovery, stable hemodynamics, and minimal respiratory and neurocognitive side effects. Based on the currently limited evidence, it may represent a favorable alternative to traditional sedatives for maintaining patient comfort during regional anesthesia procedures; however, larger, high-quality trials are warranted.
Authors
- Parisa Moradimajd (ORCID: https://orcid.org/0000-0003-3648-8979)
- Kimia Khonakdar
- Raheleh Charmchi
- Mahsa Mirshekar
- Neda Bagheri
Institutions
- Urmia University of Technology (IR)
- Iran University of Medical Sciences (IR)
- Urmia University (IR)
- Tehran University of Medical Sciences (IR)
- Mazandaran University of Medical Sciences (IR)
Publication Details
- Journal
- BMC Anesthesiology
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1186/s12871-026-03669-3
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.00